Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

05 May 2022

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2022 ,inter alia, to consider and approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2022. 2. Any other matter with the permission of the board which the Board may think fit.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

29 Apr 2022

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Increase Of Capital By Issue Of Bonus Shares …

BSE India

Apropos the captioned subject please be informed that the Board of Directors have in the allotment meeting held on April 29, 2022 alloted 19,93,12,000 bonus equity shares to the shareholders entitled for these shares subsequently increasing the paid up and issued capital of the Company from Rs. 19,93,12,000/-(divided into 19,93,12,000 equity shares of the face value of Rs.1/-each) to Rs. 39,86,24,000/-(divided into 39,86,24,000 equity shares of the face value of Rs.1/-each). We further wish to inform that the said 19,93,12,000 bonus shares will be credited to the account of respective shareholders on or before May 6,2022. This is for your information and records pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

27 Apr 2022

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shah Enterprise

pdf

Shree Ganesh Bio-Tech (India) Ltd.

27 Apr 2022

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shah Enterprise

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Apr 2022

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Format of Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Biotech (India) Ltd 2CINL70101WB1982PLC121196 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Namita Acharya Designation: CS EmailId: shreeganeshbiotechindialtd@gmail.com Name of the Chief Financial Officer: Varun Aghara Designation: CFO EmailId: shreeganeshbiotechindialtd@gmail.com Date: 25/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Apr 2022

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Format of Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Biotech (India) Ltd 2CINL70101WB1982PLC121196 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Ms. Namita Acharya Designation: CS EmailId: shreeganeshbiotechindialtd@gmail.com Name of the Chief Financial Officer: Mrs. Varun Aghara Designation: CFO EmailId: shreeganeshbiotechindialtd@gmail.com Date: 25/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

15 Apr 2022

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Certificate Under Regulation 40(9) Of SEBI …

BSE India

With reference to the above, please find enclosed Certificate under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 of the Company for the year ended 31.03.2022. Please find above and acknowledge the same. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

09 Apr 2022

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Shree Ganesh Biotech (India) Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Shree Ganesh Bio-Tech (India) Ltd.

09 Apr 2022

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & …

BSE India

The members has approved special resolutions through Postal Ballot Notice dated 7th March 2022 for Issue of Bonus Shares and increase in Authorised Share Capital of the company and consequent alteration in Capital Clause of Memorandum of Association of the Company This is for your information and records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

09 Apr 2022

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Results Of Postal Ballot Notice Dated 7Th March …

BSE India

With reference to the captioned subject and in respect of submission of the postal ballot notice dated 7th March 2022 seeking approval of members of the Company by way of Special Resolutions for approval of (1) Issue of Bonus Shares (2) Increase in Authorized Share Capital of the company and consequent alteration in Capital Clause of Memorandum of Association of the Company. We hereby inform you that Ms. CS Daksha Negi, Practicing Company Secretary, who was appointed as the Scrutinizer for the aforesaid Postal Ballot process has submitted her Report on 9th April 2022. In accordance with the said Report, the members of the Company have approved Special Resolutions as embodied in the Postal Ballot Notice dated 7th March 2022 with requisite majority. We are enclosing herewith Results of Postal Ballot in the prescribed format along with the report of Scrutinizer dated 9th April 2022. The same is also being uploaded on Company''s website. Thanking you,

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

272 Votes:

Buy 73.53%

Sell 8.82%

Hold 17.65%